SOLU-MEDROL
- Product NDC
- 70518-2023
- 11-digit product format
- 705182023
- Labeler code
- 70518
- Product ID
- 70518-2023_499b1561-882b-8553-e063-6294a90ad423
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- methylprednisolone sodium succinate
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- REMEDYREPACK INC.
- Application
- NDA011856
- Marketing category
- NDA
- Marketing start
- 2019-04-15
- Substance
- METHYLPREDNISOLONE SODIUM SUCCINATE
- Active strength
- 125 mg/2mL
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 70518-2023 | D | Discontinued by firm | 2026-08-17 | ||
| excluded package | package | 70518-2023 | 70518-2023-2 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 70518-2023-2 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 70518-2023-2 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 70518-2023-2 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 70518-2023-2 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 70518-2023-2 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 70518-2023-2 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 70518-2023-1 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 70518-2023-2 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 70518-2023-1 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 70518-2023-2 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70518-2023-1 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70518-2023-2 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 70518-2023-1 | ad56d346431e… | cc804d4bbf1e… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 70518-2023-2 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 70518-2023-1 | 367a005e9d99… | 383a685ebd0f… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 70518-2023-2 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 70518-2023-1 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 70518-2023-2 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N011856-003 | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | EQ 40MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N011856-004 | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N011856-005 | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N011856-006 | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | |
| N011856-007 | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 1985-02-27 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N011856-003 | AP |
| N011856-004 | AP |
| N011856-005 | AP |
| N011856-006 | AP |
| N011856-007 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N011856-003 | SOLU-MEDROL | EQ 40MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N011856-004 | SOLU-MEDROL | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N011856-005 | SOLU-MEDROL | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N011856-006 | SOLU-MEDROL | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N011856-007 | SOLU-MEDROL | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 1985-02-27 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N011856-003 | SOLU-MEDROL | EQ 40MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N011856-004 | SOLU-MEDROL | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N011856-005 | SOLU-MEDROL | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N011856-006 | SOLU-MEDROL | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N011856-007 | SOLU-MEDROL | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 1985-02-27 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N011856-003 | SOLU-MEDROL | EQ 40MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N011856-004 | SOLU-MEDROL | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N011856-005 | SOLU-MEDROL | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N011856-006 | SOLU-MEDROL | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N011856-007 | SOLU-MEDROL | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 1985-02-27 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N011856-003 | SOLU-MEDROL | EQ 40MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N011856-004 | SOLU-MEDROL | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N011856-005 | SOLU-MEDROL | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N011856-006 | SOLU-MEDROL | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N011856-007 | SOLU-MEDROL | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 1985-02-27 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N011856-003 | SOLU-MEDROL | EQ 40MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N011856-004 | SOLU-MEDROL | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N011856-005 | SOLU-MEDROL | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N011856-006 | SOLU-MEDROL | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N011856-007 | SOLU-MEDROL | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 1985-02-27 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N011856-003 | SOLU-MEDROL | EQ 40MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N011856-004 | SOLU-MEDROL | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N011856-005 | SOLU-MEDROL | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N011856-006 | SOLU-MEDROL | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N011856-007 | SOLU-MEDROL | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 1985-02-27 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N011856-003 | SOLU-MEDROL | EQ 40MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N011856-004 | SOLU-MEDROL | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N011856-005 | SOLU-MEDROL | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N011856-006 | SOLU-MEDROL | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N011856-007 | SOLU-MEDROL | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 1985-02-27 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N011856-003 | SOLU-MEDROL | EQ 40MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N011856-004 | SOLU-MEDROL | EQ 125MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N011856-005 | SOLU-MEDROL | EQ 500MG BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N011856-006 | SOLU-MEDROL | EQ 1GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS, Approved before 1982 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N011856-007 | SOLU-MEDROL | EQ 2GM BASE/VIAL | INJECTABLE / INJECTION | AP | RLD, RS | 1985-02-27 | 2680178bc6a6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N011856-003 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N011856-004 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N011856-005 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N011856-006 | AP | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N011856-007 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N011856-003 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N011856-004 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N011856-005 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N011856-006 | AP | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N011856-007 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N011856-003 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N011856-004 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N011856-005 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N011856-006 | AP | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N011856-007 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N011856-003 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N011856-004 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N011856-005 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N011856-006 | AP | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N011856-007 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N011856-003 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N011856-004 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N011856-005 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N011856-006 | AP | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N011856-007 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N011856-003 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N011856-004 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N011856-005 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N011856-006 | AP | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N011856-007 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N011856-003 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N011856-004 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N011856-005 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N011856-006 | AP | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N011856-007 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N011856-003 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N011856-004 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N011856-005 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N011856-006 | AP | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N011856-007 | AP | 1 | 2680178bc6a6… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- SOLU-MEDROL
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| METHYLPREDNISOLONE SODIUM SUCCINATE | 125 mg/2mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| LEC9GKY20K | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b3918abe-5cd1-b0ce-abd7-2dd6732cde26 | Product name | 5 | 20260128 |
| e1637c7c-52c4-49a3-b36b-61be755aab29 | Product name | 4 | 20230717 |
| 9eb3e96d-a1d4-4de3-aa3d-a629eea44815 | Product name | 4 | 20220316 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-2023-0 | SOLU-MEDROL | 2 mL in 1 VIAL | INJECTION, POWDER, FOR SOLUTION | 2 | 12 | |
| 70518-2023-1 | SOLU-MEDROL | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 12 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-2023 | SOLU-MEDROL (METHYLPREDNISOLONE SODIUM SUCCINATE) INJECTION, POWDER, FOR SOLUTION [REMEDYREPACK INC.] | 8 | Current NDC, Legacy NDC, 2 package rows | 20250308_1d5ef347-2e9a-432f-9a88-a7c4ba300267.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Sportpharm LLC | 0cb0ba76-067f-46c4-a5d8-b585d5ecafe3 | 2026-07-23 | Warnings, Adverse reactions | 011856 NDA011856 |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 68ef8ec4-16de-4a8c-8696-b09359660380 | 2026-07-17 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | 7271310c-7764-4812-aa30-a5e90987c7a9 | 2026-06-25 | Warnings, Adverse reactions | 011856 NDA011856 |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Henry Schein, Inc. | ea2f9b6f-2375-40a6-8b97-b607b9f3ac63 | 2026-06-04 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | A-S Medication Solutions | 8e5997ed-f4a5-43f7-abbd-c8e2219fe0e9 | 2026-05-29 | Warnings, Adverse reactions | 011856 NDA011856 |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 2af28649-2553-4bcc-9cb1-c73f7cec76d5 | 2026-05-20 | Warnings, Adverse reactions | 011856 NDA011856 |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Henry Schein, Inc. | decceb81-e922-4b72-a278-3ed80f4adb04 | 2026-03-18 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | REMEDYREPACK INC. | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 2026-01-30 | Warnings, Adverse reactions | 011856 NDA011856 70518-2023 |
| Solu-Medrol | METHYLPREDNISOLONE SODIUM SUCCINATE | Cardinal Health 107, LLC | 7e38b09c-da41-4ee3-8f99-812d3276d551 | 2025-12-19 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | ProPharma Distribution | 42df21df-9284-4505-e063-6294a90a7024 | 2025-12-18 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Pharmacia & Upjohn Company LLC | cd99be87-c8d9-48d6-a8e5-e081052e3f19 | 2025-12-02 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | ProPharma Distribution | 38698075-ac58-b5a4-e063-6294a90a7848 | 2025-07-18 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT | SOLU-MEDROL(R) METHYLPREDNISOLONE SODIUM SUCCINAT | HF Acquisition Co LLC, DBA HealthFirst | 99b3c99a-79d5-6c54-e053-2a95a90a28bc | 2025-01-08 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | SOLU-MEDROL | HF Acquisition Co. LLC, DBA HealthFirst | 74e5060c-8426-1b77-e053-2a91aa0a1f13 | 2024-02-22 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | SOLU-MEDROL | HF Acquisition Co. LLC, DBA HealthFirst | 74e448ed-f4b4-8d09-e053-2991aa0a7500 | 2024-01-29 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Medical Purchasing Solutions, LLC | 6a26a977-95dd-cdae-e053-2a91aa0a8b0a | 2023-05-30 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Medical Purchasing Solutions, LLC | dd2bfa31-9eae-2baa-e053-2a95a90a9db7 | 2023-05-23 | Warnings, Adverse reactions | 011856 NDA011856 |
| SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | Medical Purchasing Solutions, LLC | b635e21b-d68d-f60b-e053-2995a90a0f46 | 2023-05-08 | Warnings, Adverse reactions | 011856 NDA011856 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1743704 | methylPREDNISolone sodium succinate 125 MG Injection | PSN | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 12 |
| 1743707 | SOLU-Medrol 125 MG Injection | PSN | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 12 |
| 1743707 | methylprednisolone 125 MG Injection [Solu-Medrol] | SBD | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 12 |
| 1743704 | methylprednisolone 125 MG Injection | SCD | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 12 |
| 1743704 | methylprednisolone (as methylprednisolone sodium succinate) 125 MG Injection | SY | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 12 |
| 1743707 | Solu-Medrol (as methylprednisolone sodium succinate) 125 MG Injection | SY | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 12 |
| 1743707 | Solu-Medrol 125 MG Injection | SY | 1d5ef347-2e9a-432f-9a88-a7c4ba300267 | 12 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-2023-0 | 70518202300 | 2 mL in 1 VIAL | 2 ml | Historical | ||||
| 70518-2023-1 | 70518202301 | 25 VIAL in 1 CARTON (70518-2023-1) / 2 mL in 1 VIAL (70518-2023-0) | 25 vial | 2019-04-15 | 0000-00-00 | No | No | Current |
| 70518-2023-2 | 70518202302 | 25 VIAL in 1 CARTON (70518-2023-2) > 2 mL in 1 VIAL (70518-2023-3) | 25 vial | 2021-08-27 | 0000-00-00 | No | No | Current |